JoJo Siwa hinted at big “plans for 2026” on TikTok and updated her bio to reflect her full name Joelle Siwa, prompting fans ...

A Bristol, Virginia police officer has filed a $200,000 defamation lawsuit against a woman who was removed from the Hard Rock ...

Why has Jon Hamm been dancing in ecstasy all over your Instagram and TikTok feeds lately? Well, it's a story that starts with an Apple TV show from earlier this year and ends with Millennial nostalgia ...

Fifteen years after Animal and Cannibal, Kesha is finally feeling glittery again. Now that her long legal battle with producer Dr. Luke is over, she’s ready to reembrace her career breakthrough, which ...

Kirsty Hatcher is an Associate Editor on the People.com Morning Team. She has been working at PEOPLE since 2023. Her work previously appeared on ok.co.uk, in OK! Magazine and Reach PLC magazines. Kim ...

Eli Lilly on Monday announced new price cuts for its popular weight loss drug Zepbound, broadening access for patients and driving greater use of the company’s digital healthcare platform, LillyDirect ...

Eli Lilly delivered 54% revenue growth in Q3 2025, raised full-year guidance, and remains a defensive haven amid market volatility. LLY's obesity and diabetes franchise, led by Zepbound, Mounjaro, and ...

Eli Lilly (LLY) shares rose 1.7% shortly after the market opened on Friday to exceed $1T in market capitalization, becoming the first healthcare company to reach the milestone, fueled by investor ...

Sen. Ruben Gallego (D-Ariz.) is asking for more information on Eli Lilly’s recently announced agreement with the Trump administration regarding the sale of its GLP-1 medication. In a letter to Lilly ...

Forbes contributors publish independent expert analyses and insights. Monica is an entertainment reporter covering TV, film, and music. DANCING WITH THE STARS - "20th Birthday Party" - It's time to ...

Novo Nordisk A/S is undercutting arch-rival Eli Lilly & Co. on obesity drugs for cash-pay patients, showing its willingness to compete on price as it tries to claw back a larger share of the US market ...

Eli Lilly is inking a $100 million-plus biobucks deal with Insilico Medicine in hopes of using artificial intelligence to discover new drugs. The Indianapolis Big Pharma will combine Insilico’s Pharma ...